Article
Comparison of the effects of genistein and zoledronic acid on the bone loss in OPG-deficient mice.
Bone - 1 May 2008
Liu Jianghua, Xu Kang, Wen Gebo, Guo Hui, Li San, Wu Xianping, Dai Ruchun, Sheng Zhifeng, Liao Eryuan
Abstract excerpt
UNLABELLED: Using osteoprotegerin (OPG)-knockout mice, we demonstrated that in vivo the effects of both genistein and 17beta-estradiol (E2) on bone metabolism were completely abolished. In contrast, zoledronic acid could effectively suppress bone resorption and prevent bone loss. INTRODUCTION: Th...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
